OpenURL Connection Search

Select item for more details and to access through your institution.

Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease.
Published in:
2024
By:
- Houwing, Maite E.;
- Bos, Jennifer;
- van Wijk, Richard;
- van Beers, Eduard J.;
- Cnossen, Marjon H.;
- Rab, Minke A. E.;
- van Beers, E.J.;
- Biemond, B.J.;
- Beijlevelt, M.;
- Brons, P.P.T.;
- Cnossen, M.H.;
- Eckhardt, C.;
- Fijnvandraat, K.;
- Heijboer, H.;
- Hofstede, F.;
- Kerkhoffs, J.L.H.;
- Mäkelburg, A.B.U.;
- Nur, E.;
- Ootjers, C.S.;
- de Pagter, P.J.
Publication type:
Letter to the Editor
Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients.
Published in:
British Journal of Haematology, 2022, v. 197, n. 4, p. 497, doi. 10.1111/bjh.18145
By:
- Swinkels, Maurice;
- Atiq, Ferdows;
- Bürgisser, Petra E.;
- van Moort, Iris;
- Meijer, Karina;
- Eikenboom, Jeroen;
- Fijnvandraat, Karin;
- van Galen, Karin P. M.;
- de Meris, Joke;
- Schols, Saskia E. M.;
- van der Bom, Johanna G.;
- Cnossen, Marjon H.;
- Voorberg, Jan;
- Leebeek, Frank W. G.;
- Bierings, Ruben;
- Jansen, A. J. Gerard;
- Fijnvandraat, K.;
- Coppens, M.;
- de Meris, J.;
- Nieuwenhuizen, L.
Publication type:
Article
Long‐term follow‐up of neonatal intracranial haemorrhage in children with severe haemophilia.
Published in:
British Journal of Haematology, 2020, v. 190, n. 2, p. e101, doi. 10.1111/bjh.16740
By:
- Andersson, Nadine G.;
- Wu, Runhui;
- Carcao, Manuel;
- Claeyssens‐Donadel, Ségolène;
- Kobelt, Rainer;
- Liesner, Ri;
- Mäkipernaa, Anne;
- Ranta, Susanna;
- Ljung, Rolf;
- Auerswald, G.;
- Barnes, C.;
- Chalmers, E.;
- Chambost, H.;
- Clausen, N.;
- Dunn, A.L.;
- Escuriola Ettinghausen, C.;
- Fischer, K.;
- Fijnvandraat, K.;
- Geet, C.;
- Hoffmann, M.
Publication type:
Article
Prevalence and Incidence of Non-neutralizing Antibodies in Congenital Hemophilia A— A Systematic Review and Meta-Analysis.
Published in:
Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00563
By:
- Abdi, A.;
- Bordbar, M. R.;
- Hassan, S.;
- Rosendaal, F. R.;
- van der Bom, J. G.;
- Voorberg, J.;
- Fijnvandraat, K.;
- Gouw, S. C.
Publication type:
Article
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients.
Published in:
European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 237, doi. 10.1007/s00228-021-03173-2
By:
- Preijers, T.;
- van Spengler, M. W. F.;
- Meijer, K.;
- Fijnvandraat, K.;
- Fischer, K.;
- Leebeek, F. W. G.;
- Cnossen, M. H.;
- Mathôt, R. A. A.
Publication type:
Article
European principles of inhibitor management in patients with haemophilia: implications of new treatment options.
Published in:
2020
By:
- Hermans, C.;
- Giangrande, P. L. F.;
- O'Mahony, B.;
- de Kleijn, P.;
- Bedford, M.;
- Batorova, A.;
- Blatný, J.;
- Jansone, K.;
- on behalf of the European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD);
- Astermark, J.;
- Crato, M.;
- d'Oiron, R.;
- Dougall, A.;
- Fijnvandraat, K.;
- Grønhaug, S.;
- Jiménez-Yuste, V.;
- Jokić, M.;
- Lobet, S.;
- Nolan, B.;
- Peyvandi, F.
Publication type:
Letter
A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 881, doi. 10.1002/cpt.3203
By:
- Janssen, Alexander;
- Smalbil, Louk;
- Bennis, Frank C.;
- Cnossen, Marjon H.;
- Mathôt, Ron A. A.;
- Cnossen, M.H.;
- Mathôt, R.A.A.;
- Leebeek, F.W.G.;
- Coppens, M.;
- Fijnvandraat, K.;
- Meijer, K.;
- Schols, S.E.M.;
- Eikenboom, H.C.J.;
- Schutgens, R.E.G.;
- Heubel‐Moenen, F.;
- Nieuwenhuizen, L.;
- Ypma, P.;
- Driessens, M.H.E.;
- van Vliet, I.;
- Kruip, M.J.H.A.
Publication type:
Article
Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 8, p. 1100, doi. 10.1002/psp4.12828
By:
- Janssen, Alexander;
- Hoogendoorn, Mark;
- Cnossen, Marjon H.;
- Mathôt, Ron A. A.;
- Cnossen, M. H.;
- Reitsma, S. H.;
- Leebeek, F. W. G.;
- Mathôt, R. A. A.;
- Fijnvandraat, K.;
- Coppens, M.;
- Meijer, K.;
- Schols, S. E. M.;
- Eikenboom, H. C. J.;
- Schutgens, R. E. G.;
- Beckers, E. A. M.;
- Ypma, P.;
- Kruip, M. J. H. A.;
- Polinder, S.;
- Tamminga, R. Y. J.;
- Brons, P.
Publication type:
Article
Deep compartment models: A deep learning approach for the reliable prediction of time‐series data in pharmacokinetic modeling.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 7, p. 934, doi. 10.1002/psp4.12808
By:
- Janssen, Alexander;
- Leebeek, Frank W. G.;
- Cnossen, Marjon H.;
- Mathôt, Ron A. A.;
- Fijnvandraat, K.;
- Coppens, M.;
- Meijer, K.;
- Schols, S. E. M.;
- Eikenboom, H. C. J.;
- Schutgens, R. E. G.;
- Beckers, E. A. M.;
- Ypma, P.;
- Kruip, M. J. H. A.;
- Polinder, S.;
- Tamminga, R. Y. J.;
- Brons, P.;
- Fischer, K.;
- van Galen, K. P. M.;
- Nieuwenhuizen, L.;
- Driessens, M. H. E.
Publication type:
Article
HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 509, doi. 10.1111/j.1365-2516.2004.01011.x
By:
- Bril, W. S.;
- P. E. Maclean;
- P. H. P. Kaijen;
- van den Brink, E. N.;
- Lardy, N. M.;
- K. Fijnvandraat;
- M. Peters;
- Voorberg, J.
Publication type:
Article
The impact of unaware carriership on the clinical presentation of haemophilia.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 560, doi. 10.1111/j.1365-2516.2004.00955.x
By:
- MaClean, P. E.;
- Fijnvandraat, K.;
- Beijlevelt, M.;
- Peters, M.
Publication type:
Article
Emotional adjustment of children and adolescents with haemophilia in relation to the HIV threat.
Published in:
Haemophilia, 1997, v. 3, n. 1, p. 39, doi. 10.1046/j.1365-2516.1997.00076.x
By:
- BOSWERGER, M. G. C.;
- FIJNVANDRAAT, K.;
- VAN VELDHUIZEN, A. M. H.;
- ROSENDAAL, F. R.;
- PETERS, M.
Publication type:
Article
Early-Onset Thrombocytopenia in Small-For-Gestational-Age Neonates: A Retrospective Cohort Study.
Published in:
PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0154853
By:
- Fustolo-Gunnink, S. F.;
- Vlug, R. D.;
- Smits-Wintjens, V. E. H. J.;
- Heckman, E. J.;
- te Pas, A. B.;
- Fijnvandraat, K.;
- Lopriore, E.
Publication type:
Article
Neonatal bleeding in haemophilia: a European cohort study.
Published in:
British Journal of Haematology, 2012, v. 156, n. 3, p. 374, doi. 10.1111/j.1365-2141.2011.08967.x
By:
- Richards, M.;
- Lavigne Lissalde, G.;
- Combescure, C.;
- Batorova, A.;
- Dolan, G.;
- Fischer, K.;
- Klamroth, R.;
- Lambert, T.;
- Lopez-Fernandez, M.;
- Pérez, R.;
- Rocino, A.;
- Fijnvandraat, K.
Publication type:
Article
Measuring anxiety and depression in young adult men with haemophilia using PROMIS.
Published in:
Haemophilia, 2022, v. 28, n. 3, p. e79, doi. 10.1111/hae.14534
By:
- Heesterbeek, M.R.;
- Luijten, M.A.J.;
- Gouw, S.C.;
- Limperg, P.F.;
- Fijnvandraat, K.;
- Coppens, M.;
- Kruip, M.J.H.A.;
- Eikenboom, J.;
- Grootenhuis, M.A.;
- Flens, G.;
- Terwee, C.B.;
- Peters, M.;
- Haverman, L.
Publication type:
Article
Perioperative replacement therapy in haemophilia B: An appeal to “B” more precise.
Published in:
Haemophilia, 2018, v. 24, n. 4, p. 611, doi. 10.1111/hae.13469
By:
- Hazendonk, H. C. A. M.;
- Preijers, T.;
- Liesner, R.;
- Chowdary, P.;
- Hart, D.;
- Keeling, D.;
- Driessens, M. H. E.;
- Laros‐van Gorkom, B. A. P.;
- van der Meer, F. J. M.;
- Meijer, K.;
- Fijnvandraat, K.;
- Leebeek, F. W. G.;
- Mathôt, R. A. A.;
- Collins, P. W.;
- Cnossen, M. H.
Publication type:
Article
Analysis of current perioperative management with Haemate® P/Humate P® in von Willebrand disease: Identifying the need for personalized treatment.
Published in:
Haemophilia, 2018, v. 24, n. 3, p. 460, doi. 10.1111/hae.13451
By:
- the “OPTI‐CLOT" and “WIN" study group;
- Hazendonk, H. C. A. M.;
- Heijdra, J. M.;
- Veerman, H. C.;
- van Moort, I.;
- Cnossen, M. H.;
- de Jager, N. C. B.;
- Mathôt, R. A. A.;
- Boender, J.;
- Leebeek, F. W. G.;
- Meijer, K.;
- Laros‐van Gorkom, B. A. P.;
- Eikenboom, J.;
- Fijnvandraat, K.
Publication type:
Article
Male gender, school attendance and sports participation are positively associated with health‐related quality of life in children and adolescents with congenital bleeding disorders.
Published in:
Haemophilia, 2018, v. 24, n. 3, p. 395, doi. 10.1111/hae.13420
By:
- Limperg, P. F.;
- Joosten, M. M. H.;
- Grootenhuis, M. A.;
- Haverman, L.;
- Fijnvandraat, K.;
- Peters, M.
Publication type:
Article
Psychosocial care for children with haemophilia and their parents in the Netherlands.
Published in:
Haemophilia, 2017, v. 23, p. 362, doi. 10.1111/hae.13186
By:
- Limperg, P.F.;
- Haverman, L.;
- Beijlevelt, M.;
- Pot, M.;
- Zaal, G.;
- Boer, W.A.;
- Fijnvandraat, K.;
- Peters, M.;
- Grootenhuis, M. A.
Publication type:
Article
Outcome measures in European patients with haemophilia.
Published in:
Haemophilia, 2017, v. 23, n. 2, p. 222, doi. 10.1111/hae.13085
By:
- Hermans, C.;
- Klamroth, R.;
- Richards, M.;
- Moerloose, P.;
- Garrido, R. P.;
- Altisent, C.;
- Astermark, J.;
- Batorova, A.;
- Carvalho, M.;
- Dolan, G.;
- Fijnvandraat, K.;
- Holme, P.A.;
- Holstein, K.;
- Jimenez‐Yuste, V.;
- Katsarou, O.;
- Kavakli, K.;
- Lambert, T.;
- Lopéz, F.;
- Pérez, R.;
- Rocino, A.
Publication type:
Article
Joint surgery in von Willebrand disease: a multicentre cross-sectional study.
Published in:
Haemophilia, 2016, v. 22, n. 2, p. 256, doi. 10.1111/hae.12834
By:
- Galen, K. P. M.;
- Meijer, K.;
- Vogely, H. C.;
- Eikenboom, J.;
- Schutgens, R. E. G.;
- Cnossen, M. H.;
- Fijnvandraat, K.;
- Bom, J. G.;
- Laros‐van Gorkom, B. A. P.;
- Leebeek, F. W. G.;
- Mauser‐Bunschoten, E. P.
Publication type:
Article
Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).
Published in:
Haemophilia, 2016, v. 22, n. 1, p. 96, doi. 10.1111/hae.12780
By:
- Rocino, A.;
- Cortesi, P. A.;
- Scalone, L.;
- Mantovani, L. G.;
- Crea, R.;
- Gringeri, A.;
- Altisent, C;
- Astermark, J;
- Diniz, MJ;
- Fijnvandraat, K;
- Klamroth, R;
- Lambert, T;
- Lavigne‐Lissalde, G;
- Lopez‐Fernandez, MF;
- Morfini, M
Publication type:
Article
Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experiment.
Published in:
Haemophilia, 2016, v. 22, n. 1, p. e1, doi. 10.1111/hae.12851
By:
- Lock, J.;
- Bekker‐Grob, E. W.;
- Urhan, G.;
- Peters, M.;
- Meijer, K.;
- Brons, P.;
- Meer, F. J. M.;
- Driessens, M. H. E.;
- Collins, P. W.;
- Fijnvandraat, K.;
- Leebeek, F. W. G.;
- Cnossen, M. H.;
- Cnossen, M.H.;
- Leebeek, F.W.G.;
- Mathôt, R.A.A.;
- Kruip, M.H.;
- Wildt, S.N.;
- Polinder, S.;
- Bekker‐Grob, E.W;
- Ista, W.G.
Publication type:
Article
Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.
Published in:
Haemophilia, 2015, v. 21, n. 3, p. e185, doi. 10.1111/hae.12670
By:
- Galen, K. P. M.;
- Sanders, Y. V.;
- Vojinovic, U.;
- Eikenboom, J.;
- Cnossen, M. H.;
- Schutgens, R. E. G.;
- Bom, J. G.;
- Fijnvandraat, K.;
- Laros‐Van Gorkom, B. A. P.;
- Meijer, K.;
- Leebeek, F. W. G.;
- Mauser‐Bunschoten, E. P.
Publication type:
Article
Inhibitors - genetic and environmental factors.
Published in:
Haemophilia, 2014, v. 20, p. 87, doi. 10.1111/hae.12412
By:
- LILLICRAP, D.;
- FIJNVANDRAAT, K.;
- SANTAGOSTINO, E.
Publication type:
Article
Inhibitors - genetic and environmental factors.
Published in:
Haemophilia, 2014, v. 20, p. 87, doi. 10.1111/hae.12412
By:
- Lillicrap, D.;
- Fijnvandraat, K.;
- Santagostino, E.
Publication type:
Article
Continuous infusion in haemophilia: current practice in Europe.
Published in:
Haemophilia, 2012, v. 18, n. 5, p. 753, doi. 10.1111/j.1365-2516.2012.02810.x
By:
- BATOROVA, A.;
- HOLME, P.;
- GRINGERI, A.;
- RICHARDS, M.;
- HERMANS, C.;
- ALTISENT, C.;
- LOPEZ-FERNÁNDEZ, M.;
- FIJNVANDRAAT, K.
Publication type:
Article
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.
Published in:
Haemophilia, 2012, v. 18, n. 3, p. 444, doi. 10.1111/j.1365-2516.2011.02645.x
By:
- DE WEE, E. M.;
- KLAIJ, K.;
- EIKENBOOM, H. C. J.;
- VAN DER BOM, J. G.;
- FIJNVANDRAAT, K.;
- LAROS-VAN GORKOM, B. A. P.;
- MAUSER-BUNSCHOTEN, E. P.;
- MEIJER, K.;
- GOVERDE, G.;
- VAN DER LINDEN, P. W. G.;
- RIJKEN, D. C.;
- LEEBEEK, F. W.G.
Publication type:
Article
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.
Published in:
Haemophilia, 2010, v. 16, n. 5, p. 747, doi. 10.1111/j.1365-2516.2010.02231.x
By:
- ASTERMARK, J.;
- ALTISENT, C.;
- BATOROVA, A.;
- DINIZ, M. J.;
- GRINGERI, A.;
- HOLME, P. A.;
- KARAFOULIDOU, A.;
- LOPEZ-FERNÁNDEZ, M. F.;
- REIPERT, B. M.;
- ROCINO, A.;
- SCHIAVONI, M.;
- von DEPKA, M.;
- WINDYGA, J.;
- FIJNVANDRAAT, K.
Publication type:
Article
Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.
Published in:
Haemophilia, 2010, v. 16, n. 102, p. 35, doi. 10.1111/j.1365-2516.2010.02215.x
By:
- van HELDEN, P. M. W.;
- VAN HAREN, S. D.;
- FIJNVANDRAAT, K.;
- MARIJKEvan den BERG, H.;
- VOORBERG, J.
Publication type:
Article
Obesity: a new disaster for haemophilic patients? A nationwide survey.
Published in:
Haemophilia, 2008, v. 14, n. 5, p. 1035, doi. 10.1111/j.1365-2516.2008.01806.x
By:
- HOFSTEDE, F. G.;
- FIJNVANDRAAT, K.;
- PLUG, I.;
- KAMPHUISEN, P. W.;
- ROSENDAAL, F. R.;
- PETERS, M.
Publication type:
Article

Found: 31

Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease.

Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients.

Long‐term follow‐up of neonatal intracranial haemorrhage in children with severe haemophilia.

Prevalence and Incidence of Non-neutralizing Antibodies in Congenital Hemophilia A— A Systematic Review and Meta-Analysis.

In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients.

European principles of inhibitor management in patients with haemophilia: implications of new treatment options.

A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia A: A Machine Learning Framework for Continuous Model Refinement.

Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling.

Deep compartment models: A deep learning approach for the reliable prediction of time‐series data in pharmacokinetic modeling.

HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg<sup>593</sup> to Cys mutation.

The impact of unaware carriership on the clinical presentation of haemophilia.

Emotional adjustment of children and adolescents with haemophilia in relation to the HIV threat.

Early-Onset Thrombocytopenia in Small-For-Gestational-Age Neonates: A Retrospective Cohort Study.

Neonatal bleeding in haemophilia: a European cohort study.

Measuring anxiety and depression in young adult men with haemophilia using PROMIS.

Perioperative replacement therapy in haemophilia B: An appeal to “B” more precise.

Analysis of current perioperative management with Haemate<sup>®</sup> P/Humate P<sup>®</sup> in von Willebrand disease: Identifying the need for personalized treatment.

Male gender, school attendance and sports participation are positively associated with health‐related quality of life in children and adolescents with congenital bleeding disorders.

Psychosocial care for children with haemophilia and their parents in the Netherlands.

Outcome measures in European patients with haemophilia.

Joint surgery in von Willebrand disease: a multicentre cross-sectional study.

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).

Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experiment.

Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.

Inhibitors - genetic and environmental factors.

Inhibitors - genetic and environmental factors.

Continuous infusion in haemophilia: current practice in Europe.

Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.

Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.

Obesity: a new disaster for haemophilic patients? A nationwide survey.